Impact of venous invasion on the efficacy of adjuvant chemotherapy in elderly patients with stage III colorectal cancer.

about

Impact of venous invasion on the efficacy of adjuvant chemotherapy in elderly patients with stage III colorectal cancer.

Item

http://www.wikidata.org/entity/Q38683073

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Impact of venous invasion on t ...... h stage III colorectal cancer.

@en

type

Item

label

Impact of venous invasion on t ...... h stage III colorectal cancer.

@en

prefLabel

Impact of venous invasion on t ...... h stage III colorectal cancer.

@en

P1476

Impact of venous invasion on t ...... th stage III colorectal cancer

@en

P2093

Kenichi Sugihara

http://www.w3.org/2001/XMLSchema#string

Kenji Kawada

http://www.w3.org/2001/XMLSchema#string

Ryuji Uozumi

http://www.w3.org/2001/XMLSchema#string

Suguru Hasegawa

http://www.w3.org/2001/XMLSchema#string

Yoshiharu Sakai

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trials.

Comparison of FOLFIRI with or without cetuximab in patients with resected stage III colon cancer; NCCTG (Alliance) intergroup trial N0147.

Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer.

S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial).

Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials.

The Benefit of Adjuvant Chemotherapy in Elderly Patients with Stage III Colorectal Cancer is Independent of Age and Comorbidity.

Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses

Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy.

Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial.

Efficacy of surgery and adjuvant therapy in older patients with colorectal cancer: a STROBE-compliant article.

P2888

s12032-017-0996-0

P304

138

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-017-0996-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Koya Hida

Saori Goto

Nobuaki Hoshino

P577

2017-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090616450

http://www.w3.org/2001/XMLSchema#string

P698

28699092

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer